Currently predicting for Thu, 4 Jun 2026

SAVA Prediction Chart

SAVA Predictions History

Latest community submissions for SAVA.
Predictor Target Session Target Price Result Direction Accuracy Score
Oct 10, 2022 $42.50 +6.45% $36.32 X 82.97% 0
Oct 10, 2022 Bullish $36.32 X 0
JS JS Pro
Oct 6, 2022 $39.97 -2.44% $42.35 X 94.38% 0
Oct 6, 2022 $43.22 +5.49% $42.35 V 97.95% 1
Oct 6, 2022 $39.76 -2.96% $42.35 X 93.88% 0
Oct 6, 2022 Bullish $42.35 V 1
JS JS Pro
Oct 3, 2022 $41.14 -1.63% $41.50 V 99.13% 3
Oct 3, 2022 $44.34 +6.01% $41.50 X 93.17% 0
Oct 3, 2022 $36.69 -12.26% $41.50 V 88.42% 1
Oct 3, 2022 Bullish $41.50 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SAVA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CASSAVA SCIENCES INC.
Cassava Sciences
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sci...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE